A detailed history of City State Bank transactions in Exact Sciences Corp stock. As of the latest transaction made, City State Bank holds 100 shares of EXAS stock, worth $5,748. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$5,748
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Jun 01, 2022

BUY
$57.56 - $82.54 $575 - $825
10 Added 11.11%
100 $7,000
Q4 2021

Mar 23, 2022

BUY
$72.5 - $100.68 $2,900 - $4,027
40 Added 80.0%
90 $7,000
Q4 2021

Mar 11, 2022

BUY
$72.5 - $100.68 $3,625 - $5,034
50 New
50 $3,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track City State Bank Portfolio

Follow City State Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of City State Bank, based on Form 13F filings with the SEC.

News

Stay updated on City State Bank with notifications on news.